Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03779854
What this trial is testing

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more
Fred Hutchinson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00054340
What this trial is testing

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT02828878
What this trial is testing

Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
Cellect Biotechnology 12
Early research (Phase 1)Study completedNCT00529035
What this trial is testing

Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 29
Large-scale testing (Phase 3)UnknownNCT06000982
What this trial is testing

Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

Who this might be right for
GVHD
Shanghai Jiao Tong University School of Medicine 138
Early research (Phase 1)UnknownNCT03214289
What this trial is testing

Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease

Who this might be right for
Stem Cell Transplant ComplicationsGraft Versus Host Disease, AcuteFecal Microbiota Transplantation
Sheba Medical Center 4
Not applicableUnknownNCT02319226
What this trial is testing

Toward Immune Biomarkers for Tolerance and GvHD in Humans

Who this might be right for
Bone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675174
What this trial is testing

Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT

Who this might be right for
GVHD - Graft-Versus-Host Disease
Northwell Health 72
Very early researchStudy completedNCT01174940
What this trial is testing

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Who this might be right for
Stem Cell Leukemia of Unclear LineageGraft Versus Host Disease
University of Kansas Medical Center 22
Not applicableNo Longer AvailableNCT02258490
What this trial is testing

Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation

Who this might be right for
Chronic Myeloid LeukemiaMyelodysplastic SyndromeAcute Myeloid Leukemia
Emory University
Early research (Phase 1)Ended earlyNCT02086513
What this trial is testing

Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Massachusetts General Hospital 17
Testing effectiveness (Phase 2)Study completedNCT01287078
What this trial is testing

Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome

Who this might be right for
Constrictive BronchiolitisBronchiolitis ObliteransGraft vs Host Disease+2 more
National Heart, Lung, and Blood Institute (NHLBI) 25
Testing effectiveness (Phase 2)Study completedNCT01491958
What this trial is testing

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Ohio State University Comprehensive Cancer Center 40
Early research (Phase 1)Study completedNCT00684008
What this trial is testing

Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

Who this might be right for
AMLCMLMDS
Cytheris, Inc. 12
Not applicableActive Not RecruitingNCT05111834
What this trial is testing

IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms

Who this might be right for
Graft Vs Host Disease
University Hospital Heidelberg 112
Testing effectiveness (Phase 2)Study completedNCT00589563
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+8 more
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808112
What this trial is testing

CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation

Who this might be right for
Graft -Versus-host-disease
Medical College of Wisconsin 72
Not applicableNo Longer AvailableNCT02026934
What this trial is testing

CliniMACS® CD34+ Reagent System for Expanded Access Use

Who this might be right for
Graft-Versus-Host Disease(GVHD)Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem CellsGraft Failure+1 more
Joseph Antin
Testing effectiveness (Phase 2)Looking for participantsNCT06450925
What this trial is testing

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Who this might be right for
Graft Vs Host DiseaseVitamin A DeficiencyVitamin D Deficiency
Children's Hospital Medical Center, Cincinnati 190
Next Page